Literature DB >> 22149976

Vegetational variation of phenolic compounds in Epilobium angustifolium.

Siiri Jürgenson1, Vallo Matto, Ain Raal.   

Abstract

Epilobium angustifolium L. herbs are used in ethnomedicine to treat benign prostate hyperplasia. The aim of the study was to investigate the phenolic contents in distinct E. angustifolium organs during the whole vegetational period from May to October. The plants were obtained from a remote habitat in Estonia and spectrophotometrically analysed for the total polyphenol, tannin, and flavonoid contents. The total polyphenol content was the highest in roots (85 mg g(-1)) and stems (67 mg g(-1)) in July. The total flavonoid content was the highest in leaves (2.36 mg g(-1)) and flowers (2.09 mg g(-1)) and it remained relatively stable during the summer months. The highest tannin content was found in small growing plants in May; in older ones it declined, whereas the absolute yield per plant was greater. In sum, the aerial organs without stems collected in July-August are the best choice to get E. angustifolium plant material with stable high phenolic content.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22149976     DOI: 10.1080/14786419.2011.643310

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  2 in total

Review 1.  Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed).

Authors:  Igor A Schepetkin; Andrew G Ramstead; Liliya N Kirpotina; Jovanka M Voyich; Mark A Jutila; Mark T Quinn
Journal:  Phytother Res       Date:  2016-05-24       Impact factor: 5.878

2.  Inventing a herbal tradition: The complex roots of the current popularity of Epilobium angustifolium in Eastern Europe.

Authors:  Renata Sõukand; Giulia Mattalia; Valeria Kolosova; Nataliya Stryamets; Julia Prakofjewa; Olga Belichenko; Natalia Kuznetsova; Sabrina Minuzzi; Liisi Keedus; Baiba Prūse; Andra Simanova; Aleksandra Ippolitova; Raivo Kalle
Journal:  J Ethnopharmacol       Date:  2019-09-30       Impact factor: 4.360

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.